Page last updated: 2024-12-11

atractylenolide i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

atractylenolide I: from Atractylodes macrocephala Koidz; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

FloraRankFlora DefinitionFamilyFamily Definition
AtractylodesgenusA plant genus of the family ASTERACEAE. Members contain hinesol and atractylon. Atractylodes rhizome is Byaku-jutsu. A. lancea rhizome is So-jutsu.[MeSH]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]
Atractylodes macrocephalaspecies[no description available]AsteraceaeA large plant family of the order Asterales, subclass Asteridae, class Magnoliopsida. The family is also known as Compositae. Flower petals are joined near the base and stamens alternate with the corolla lobes. The common name of daisy refers to several genera of this family including Aster; CHRYSANTHEMUM; RUDBECKIA; TANACETUM.[MeSH]

Cross-References

ID SourceID
PubMed CID5321018
CHEMBL ID449520
SCHEMBL ID1898423
MeSH IDM0385975

Synonyms (26)

Synonym
atractylenolide i
bdbm50241939
CHEMBL449520 ,
(4as,8as)-3,8a-dimethyl-5-methylidene-4a,6,7,8-tetrahydro-4h-benzo[f][1]benzofuran-2-one
C17885
SCHEMBL1898423
S8291
73069-13-3
CS-3669
8,9-dehydroasterolide
AKOS025119313
AC-34011
Q-100800
atractylenolidei
atractylenolide-i
atractylenolide-1
HY-N0201
8,12-epoxyeudesma-4(14),7(11),8-trien-12-one
atractylenolide i, >=98% (hplc)
atractylenolide 1
Q63396593
HMS3886N08
CCG-266793
CCG-266794
DTXSID901316467
AS-77802

Research Excerpts

Overview

Atractylenolide I (AT-I) is a natural sesquiterpene with anti-inflammatory effects. Atractylodes macrocephala Koidz, known as Baizhu in traditional Chinese medicine.

ExcerptReferenceRelevance
"Atractylenolide I (AI) is a natural sesquiterpene lactone isolated from Atractylodes macrocephala Koidz, known as Baizhu in traditional Chinese medicine. "( Atractylenolide I ameliorates cancer cachexia through inhibiting biogenesis of IL-6 and tumour-derived extracellular vesicles.
Fan, M; Fang, Q; Gu, X; Guo, X; Liu, X; Shen, Q; Wang, Y; Zhang, R; Zhang, W; Zhang, X, 2022
)
3.61
"Atractylenolide I (AT-I) is a natural sesquiterpene with anti-inflammatory effects. "( Therapeutic effect of Atractylenolide I on Aspergillus fumigatus keratitis by affecting MyD88/ NF-κB pathway and IL-1β, IL-10 expression.
Che, C; Chen, X; Liu, W; Lu, D; Lu, Z; Wang, L; Xie, J; Yan, H; Yang, H, 2023
)
2.67
"Atractylenolide I (ATL-1) is a natural herbal compound used in traditional Chinese medicine that has exhibited anti-cancer properties. "( Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
Cao, G; Huang, W; Sang, X; Shan, Q; Tang, D; Wang, K; Wu, X; Xu, X, 2020
)
3.44
"Atractylenolide I (ATL-I) is a bioactive component of Rhizoma Atractylodis macrocephalae. "( Atractylenolide I inhibits lipopolysaccharide-induced inflammatory responses via mitogen-activated protein kinase pathways in RAW264.7 cells.
Chen, R; Ji, G; Zheng, J, 2014
)
3.29
"Atractylenolide I (AO-1) is a naturally occurring sesquiterpene lactone known to change the conformational ensemble of human MD-2 on EOC cells."( Atractylenolide I modulates ovarian cancer cell-mediated immunosuppression by blocking MD-2/TLR4 complex-mediated MyD88/NF-κB signaling in vitro.
Cheng, J; Huang, J; Huang, W; Liu, H; Ma, S; Mi, K; Zha, X; Zhang, G; Zhu, Y, 2016
)
2.6
"Atractylenolide I is an anti-inflammation agent."( Inhibitory effect of atractylenolide I on angiogenesis in chronic inflammation in vivo and in vitro.
Duan, H; He, L; Wang, C, 2009
)
1.39

Effects

ExcerptReferenceRelevance
"Atractylenolide I has not been reported in mushrooms or rice as of yet."( Identification of an anticancer compound against HT-29 cells from Phellinus linteus grown on germinated brown rice.
Cho, JY; Jeon, TI; Jung, CH; Moon, JH; Park, DK, 2013
)
1.11

Toxicity

ExcerptReferenceRelevance
"Hepatotoxicity is a well-known adverse effect of many substances, with toxicity often resulting from interactions of drugs with other drug-like substances."( Implications for herbal polypharmacy: coumarin-induced hepatotoxicity increased through common herbal phytochemicals astragaloside IV and atractylenolide I.
Britza, SM; Byard, RW; Musgrave, IF, 2022
)
0.92

Pharmacokinetics

This study is aimed to assess the influence of atractylenolide I and prim-O-glucosylcimifugin on the pharmacokinetic profile of astragaloside IV. The study was carried out in rats administered with 20 g/kg Atractylodis extract.

ExcerptReferenceRelevance
" In the applications, the main pharmacokinetic parameters were firstly obtained as follows: Tmax=0."( A capillary gas chromatography-selected ion monitoring mass spectrometry method for the analysis of atractylenolide I in rat plasma and tissues, and application in a pharmacokinetic study.
Chen, Q; He, L; Wang, C; Wang, S, 2008
)
0.56
" This fully validated method was applied to a pharmacokinetic study of atractylenolide I in rats administered with 20 g/kg Atractylodis extract."( Quantitative analysis of atractylenolide I in rat plasma by LC-MS/MS method and its application to pharmacokinetic study.
Chen, B; Li, Y; Tian, Y; Wang, Z; Zhang, Y; Zhu, J, 2012
)
0.92
" This study is aimed to assess the influence of atractylenolide I and prim-O-glucosylcimifugin on the pharmacokinetic profile of astragaloside IV so as to investigate the pharmacokinetic mechanisms of the Yu-ping-feng prescription."( Pharmacokinetic Interaction of astragaloside IV with atractylenolide I and prim-O-glucosylcimifugin in male Sprague Dawley rats.
Jin, Y; Li, J; Song, J; Zheng, SR, 2014
)
0.91
" This method was successfully applied to the comparative pharmacokinetic study of Atractylenolide I, II and III in rat plasma after intragastric administration of Baizhufuling extract and Atractylodis extract."( Simultaneous determination and pharmacokinetic study of Atractylenolide I, II and III in rat plasma after intragastric administration of Baizhufuling extract and Atractylodis extract by UPLC-MS/MS.
Sun, Y; Wang, X; Wang, Y; Yan, H; Yang, M; Yu, Z; Zhang, Q; Zhao, Y, 2015
)
0.89
" To reveal the interactions of Saposhnikoviae Radix with other herbs, we conducted this study on the pharmacokinetic profile and tissue distribution of active ingredients of TXYF in rats."( [Effect of Saposhnikoviae Radix on pharmacokinetics and tissue distributions of active components in Tongxie Yaofang in rats].
Cui, WF; Ge, WJ; Li, GS; Liang, RF; Liu, X; Wei, Z; Zhang, XX, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" When the concentration of perfusion solution was increased contrarily the absorption rate constant (Ka) kept at the same level."( [Absorption kinetics of atractylenolide I in intestines of rats].
Duan, H; He, L; Wang, C, 2009
)
0.66
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Polyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)IC50 (µMol)200.00000.00011.68479.3200AID400125
Prostaglandin G/H synthase 1Homo sapiens (human)IC50 (µMol)200.00000.00021.557410.0000AID400126
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (36)

Processvia Protein(s)Taxonomy
negative regulation of endothelial cell proliferationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte chemotaxis involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukocyte migration involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
humoral immune responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxygenase pathwayPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of bone mineralizationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
dendritic cell migrationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
glucose homeostasisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
long-chain fatty acid biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of fat cell differentiationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of insulin secretionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of vascular wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of wound healingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of inflammatory response to woundingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cytokine production involved in inflammatory responsePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of cellular response to oxidative stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
leukotriene A4 biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
regulation of reactive oxygen species biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
negative regulation of sprouting angiogenesisPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
positive regulation of leukocyte adhesion to arterial endothelial cellPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipoxin biosynthetic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonic acid metabolic processPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
lipid oxidationPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
prostaglandin biosynthetic processProstaglandin G/H synthase 1Homo sapiens (human)
response to oxidative stressProstaglandin G/H synthase 1Homo sapiens (human)
regulation of blood pressureProstaglandin G/H synthase 1Homo sapiens (human)
cyclooxygenase pathwayProstaglandin G/H synthase 1Homo sapiens (human)
regulation of cell population proliferationProstaglandin G/H synthase 1Homo sapiens (human)
cellular oxidant detoxificationProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (11)

Processvia Protein(s)Taxonomy
arachidonate 5-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 12(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
iron ion bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
protein bindingPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
hydrolase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
arachidonate 8(S)-lipoxygenase activityPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
peroxidase activityProstaglandin G/H synthase 1Homo sapiens (human)
prostaglandin-endoperoxide synthase activityProstaglandin G/H synthase 1Homo sapiens (human)
protein bindingProstaglandin G/H synthase 1Homo sapiens (human)
heme bindingProstaglandin G/H synthase 1Homo sapiens (human)
metal ion bindingProstaglandin G/H synthase 1Homo sapiens (human)
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygenProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (18)

Processvia Protein(s)Taxonomy
extracellular regionPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
extracellular spacePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelope lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nucleoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
cytosolPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear matrixPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear membranePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
secretory granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
perinuclear region of cytoplasmPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
ficolin-1-rich granule lumenPolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
nuclear envelopePolyunsaturated fatty acid 5-lipoxygenaseHomo sapiens (human)
photoreceptor outer segmentProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
endoplasmic reticulum membraneProstaglandin G/H synthase 1Homo sapiens (human)
Golgi apparatusProstaglandin G/H synthase 1Homo sapiens (human)
intracellular membrane-bounded organelleProstaglandin G/H synthase 1Homo sapiens (human)
extracellular exosomeProstaglandin G/H synthase 1Homo sapiens (human)
cytoplasmProstaglandin G/H synthase 1Homo sapiens (human)
neuron projectionProstaglandin G/H synthase 1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (40)

Assay IDTitleYearJournalArticle
AID1291786Induction of apoptosis in human Jurkat T cells assessed as procaspase 9 degradation at 6.25 to 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291788Induction of apoptosis in human Jurkat T cells assessed as PARP degradation at 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291764Cytotoxicity against human Jurkat T cells assessed as growth inhibition after 12 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291781Induction of apoptosis in human U937 cells assessed as fragmented chromosomal DNA at 6.25 to 50 ug/ml after 12 to 48 hrs by agarose gel electrophoresis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291773Induction of cell death in human Jurkat T cells2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID401195Antihepatotoxic activity against carbon tetrachloride-induced cytotoxicity in rat hepatocytes assessed as GPT level at 1 mg/mL relative to control
AID1291772Induction of cell death in human U937 at 12.5 to 25 ug/ml cells after 24 hrs2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291790Induction of cell differentiation in human U937 cells assessed as upregulation of CD68 at 12.5 ug/ml after 72 hrs by flow cytometry (Rvb = 5.9%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291791Induction of cell differentiation in human U937 cells assessed as upregulation of CD14 at 6.25 ug/ml after 72 hrs by flow cytometry (Rvb = 4.3%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291767Cytotoxicity against human U937 cells assessed as growth inhibition after 12 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291780Induction of apoptosis in human Jurkat T cells assessed as cytosolic DNA fragmentation at 6.25 ug/ml after 24 hrs by ELISA reader method relative to control2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291775Cell cycle arrest in human Jurkat T cells assessed as accumulation at sub G1 phase at 25 ug/ml after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.9%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291776Cell cycle arrest in human Jurkat T cells assessed as accumulation at sub G1 phase at 50 ug/ml after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.9%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291778Cell cycle arrest in human K562 cells assessed as accumulation at sub G1 phase at 50 to 100 ug/ml after 48 hrs by propidium iodide staining based flow cytometry2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1354700Neuroprotective activity against glutamate-induced neuronal cell death in rat PC12 cells assessed as increase in cell viability pretreated for 2 hrs followed by glutamate challenge measured after 24 hrs by MTT assay2018Journal of natural products, 06-22, Volume: 81, Issue:6
Sesquiterpenoids from Chloranthus anhuiensis with Neuroprotective Effects in PC12 Cells.
AID1291770Cytotoxicity against human K562 CML cells assessed as growth inhibition treated with high doses of compound after 48 to 72 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291783Induction of apoptosis in human U937 cells assessed as procaspase 9 degradation at 6.25 to 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID714969Transactivation of p53 in human HepG2 cells expressing MDM2 promoter by transient transfection reporter assay2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Sesquiterpenoids from Atractylodes macrocephala act as farnesoid X receptor and progesterone receptor modulators.
AID1291769Cytotoxicity against human U937 cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291768Cytotoxicity against human U937 cells assessed as growth inhibition after 24 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID401451Antihepatotoxic activity against galactosamine-induced cytotoxicity in rat hepatocytes assessed as GPT level at 1 mg/mL relative to control
AID1291793Induction of cell differentiation in human K562 cells assessed as upregulation of CD14 at 50 ug/ml after 72 hrs by flow cytometry (Rvb = 6.4%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291785Induction of apoptosis in human U937 cells assessed as PARP degradation at 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID400126Inhibition of COX11998Journal of natural products, Mar, Volume: 61, Issue:3
5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea.
AID1291765Cytotoxicity against human Jurkat T cells assessed as growth inhibition after 24 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID714970Cytotoxicity against human HepG2 cells2012Bioorganic & medicinal chemistry letters, Mar-15, Volume: 22, Issue:6
Sesquiterpenoids from Atractylodes macrocephala act as farnesoid X receptor and progesterone receptor modulators.
AID1291771Induction of cell death in human K562 cells at 12.5 to 50 ug/ml after 48 hrs2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291782Induction of apoptosis in human Jurkat T cells assessed as fragmented chromosomal DNA at 6.25 to 50 ug/ml after 12 to 48 hrs by agarose gel electrophoresis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291777Cell cycle arrest in human U937 cells assessed as accumulation at sub G1 phase at 50 to 100 ug/ml after 24 hrs by propidium iodide staining based flow cytometry2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291797Induction of phagocytosis in human K562 cells at 25 to 50 ug/ml incubated for 4 to 6 days measured using fluorescent latex beads after 2 hrs by flow cytometry relative to control2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291796Induction of phagocytosis in human U937 cells at 6.25 to 12.5 ug/ml measured using fluorescent latex beads after 2 hrs by flow cytometry relative to control2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291792Induction of cell differentiation in human K562 cells assessed as upregulation of CD14 at 12.5 ug/ml after 72 hrs by flow cytometry (Rvb = 6.4%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291766Cytotoxicity against human Jurkat T cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291784Induction of apoptosis in human U937 cells assessed as procaspase 3 degradation at 6.25 to 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291774Cell cycle arrest in human Jurkat T cells assessed as accumulation at sub G1 phase at 12.5 ug/ml after 24 hrs by propidium iodide staining based flow cytometry (Rvb = 0.9%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291789Induction of cell differentiation in human U937 cells assessed as upregulation of CD68 at 6.25 ug/ml after 72 hrs by flow cytometry (Rvb = 5.9%)2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291779Induction of apoptosis in human U937 cells assessed as cytosolic DNA fragmentation at 6.25 ug/ml after 24 hrs by ELISA reader method relative to control2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID1291787Induction of apoptosis in human Jurkat T cells assessed as procaspase 3 degradation at 6.25 to 50 ug/ml after 24 hrs by Western blot analysis2016Bioorganic & medicinal chemistry letters, Apr-15, Volume: 26, Issue:8
Induction of apoptosis and differentiation by atractylenolide-1 isolated from Atractylodes macrocephala in human leukemia cells.
AID400125Inhibition of 5-lipoxygenase1998Journal of natural products, Mar, Volume: 61, Issue:3
5-Lipoxygenase and cyclooxygenase-1 inhibitory active compounds from Atractylodes lancea.
AID1347411qHTS to identify inhibitors of the type 1 interferon - major histocompatibility complex class I in skeletal muscle: primary screen against the NCATS Mechanism Interrogation Plate v5.0 (MIPE) Libary2020ACS chemical biology, 07-17, Volume: 15, Issue:7
High-Throughput Screening to Identify Inhibitors of the Type I Interferon-Major Histocompatibility Complex Class I Pathway in Skeletal Muscle.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's2 (2.38)18.2507
2000's13 (15.48)29.6817
2010's49 (58.33)24.3611
2020's20 (23.81)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.56

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.56 (24.57)
Research Supply Index4.45 (2.92)
Research Growth Index5.43 (4.65)
Search Engine Demand Index21.17 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.56)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews3 (3.53%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other82 (96.47%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]